Polish medtech gains momentum. Domestic companies bet on innovation, boldness and capital
Polish medtech companies are preparing to compete in one of the most demanding markets in the world. Their solutions aim to improve patient treatment and make the work of hospitals and clinics easier.

Ibrahim Boran · Unsplash License
- 0views
- 0likes and saves
- 0skips
In brief
- Polish medtech companies are developing solutions for patients, hospitals and clinics, and some of them have already entered production.
- Many projects are being carried out thanks to the Ścieżka SMART programme, co-financed from European Funds.
- Developing medical devices requires lengthy testing and access to capital.
Domestic producers aim for the global market
Polish companies in the medical technology sector are developing solutions intended both for patients and for hospitals and clinics. Some of them have already passed initial tests, and a few products have entered production (Polski medtech nabiera rozpędu. Te firmy pokazują, że innowacje potrzebują odwagi i kapitału – Business Insider Polska).
Support from European Funds
Many projects are being carried out thanks to the Ścieżka SMART programme, co-financed from the European Funds for a Modern Economy. Thanks to it, entrepreneurs can conduct ambitious research and development work that would be harder to finance without external funding (Polski medtech nabiera rozpędu. Te firmy pokazują, że innowacje potrzebują odwagi i kapitału – PARP).
Innovation takes time and capital
As the Polish Agency for Enterprise Development points out, the development of new medical devices involves a long cycle of testing and implementation. Investment courage and access to capital are therefore just as important as the idea itself. Company representatives stress that these factors determine whether a solution reaches patients.
What's next
Companies plan further clinical tests and are looking for partners who can help them enter foreign markets. Their success depends on whether they can maintain the pace of work and convince investors to finance subsequent stages.
Sources
Discussion0
- No comments from this perspective yet. Be the first.